Awakn Life Sciences (XCNQ:AWKN) Debt-to-Equity : 0.00 (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Debt-to-Equity?

Awakn Life Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was C$0.00 Mil. Awakn Life Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was C$0.00 Mil. Awakn Life Sciences's Total Stockholders Equity for the quarter that ended in Jan. 2024 was C$-1.53 Mil. Awakn Life Sciences's debt to equity for the quarter that ended in Jan. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Awakn Life Sciences's Debt-to-Equity or its related term are showing as below:

XCNQ:AWKN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.4 Med: 0.53 Max: 2.71
Current: -1.62

During the past 4 years, the highest Debt-to-Equity Ratio of Awakn Life Sciences was 2.71. The lowest was 0.40. And the median was 0.53.

XCNQ:AWKN's Debt-to-Equity is not ranked
in the Biotechnology industry.
Industry Median: 0.14 vs XCNQ:AWKN: -1.62

Awakn Life Sciences Debt-to-Equity Historical Data

The historical data trend for Awakn Life Sciences's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Debt-to-Equity Chart

Awakn Life Sciences Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Debt-to-Equity

0.40

0.53

2.71

Awakn Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Debt-to-Equity	Get a 7-Day Free Trial								2.71	-3.35	-	-	-

Competitive Comparison of Awakn Life Sciences's Debt-to-Equity

For the Biotechnology subindustry, Awakn Life Sciences's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Awakn Life Sciences's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's Debt-to-Equity falls into.

Awakn Life Sciences Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Awakn Life Sciences's Debt to Equity Ratio for the fiscal year that ended in Jan. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	-1.53
	=	0.00

Awakn Life Sciences's Debt to Equity Ratio for the quarter that ended in Jan. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	-1.53
	=	0.00

Awakn Life Sciences (XCNQ:AWKN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Awakn Life Sciences Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences (XCNQ:AWKN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (XCNQ:AWKN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

AWKNF:USA 954:Germany

Address

301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2

Website

https://www.awaknlifesciences.com

Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (XCNQ:AWKN) Headlines

No Headlines